SCHEMBL24492873

SCHEMBL24492873

c1ccc(-n2c3ccncc3c3cc(-c4cc(-c5cccc(-c6cncc(-c7ccncc7)c6)c5)cc(-c5cccc(-c6cncc(-c7ccncc7)c6)c5)c4)ccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 2/20 0.39
▸ PIK3CA P42336 2/20 0.39
▸ MAPK10 P53779 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ NOTUM Q6P988 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.35
▸ IMPDH2 P12268 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ PRKCI P41743 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ KIF11 P52732 1/20 0.35
▸ KDR P35968 1/20 0.34
▸ HTR6 P50406 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24492822 0.96 MKNK1 (0.42) MKNK1PIK3CAMAPK10DYRK1ANOTUM
SCHEMBL24493047 0.93 CYP19A1 (0.40) MKNK1PIK3CADYRK1AMAPTMEN1
SCHEMBL11987859 0.92 MAPK10 (0.41) MKNK1PIK3CAMAPK10MAPTMEN1
SCHEMBL24492827 0.91 KDM4E (0.45) MKNK1PIK3CADYRK1ANOTUMMAPT
SCHEMBL24492900 0.90 CYP19A1 (0.42) MKNK1PIK3CADYRK1AMAPTMEN1
SCHEMBL25946455 0.90 ATM (0.42) MKNK1PIK3CAMAPK10DYRK1ANOTUM
SCHEMBL24492823 0.89 ATM (0.39) MAPK10DYRK1AMAPTMEN1KMT2A
SCHEMBL11987863 0.89 KDM4E (0.41) MKNK1MAPK10MAPTMEN1HSP90AA1
SCHEMBL13471366 0.89 KIF11 (0.39) MKNK1PIK3CAMAPK10DYRK1ANOTUM
SCHEMBL12162410 0.87 MAPK10 (0.40) MKNK1PIK3CAMAPK10DYRK1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2022-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220177454-A1 TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT ETV6, LEF1, TEAD2 MKNK1 4036/4885PIK3CA 2890/4885MAPK10 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback